## Abstract Mutational analysis of __KRAS__ codons 12 and 13 is standard for patients with metastatic colorectal cancer since mutations in these codons predict lack of response to anti‐EGFR therapies. However, even among patients whose tumors are wildtype for __KRAS__ codons 12 and 13, only a subse
KRAS,BRAF,EGFRandHER2gene status in a Spanish population of colorectal cancer
✍ Scribed by Marta Herreros-Villanueva; Maximiliano Rodrigo; Manuel Claver; Pilar Muñiz; Enrique Lastra; Carlos García-Girón; Maria Jesus Coma del Corral
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 180 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0301-4851
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Iron status was assessed in a population of 196 schoolchildren and adolescents divided into three age groups: 6–7 years (__n__ = 60), 10–12 years (__n__ = 63) and 13–15 years (__n__ = 73). All subjects were from the Vélez‐Málaga area (province of Málaga) in southern Spain. Nutrient inta
## Abstract Epidemiological observations suggest that cancer arises from chronically inflamed tissues. Inflammatory bowel disease (IBD) is a typical example since patients with longstanding IBD are at increased risk for development of colorectal cancer (CRC). Therefore, genetic factors predisposing
## Abstract Which carcinogens are of influence in the development of human colorectal cancers remains a question; one answer could be the finding that specific polymorphisms in xenobiotic metabolizing enzymes are related to particular mutations in cancer genes. __KRAS2__ and __TP53__ gene mutations